Gyros taps further into GE's Asian biopharma channels
This article was originally published in Clinica
GE Healthcare is to distribute Gyros's nanolitre-scale immunoassays to biopharmaceutical companies in China, Taiwan and Hong Kong. GE is already selling the Swedish company's products in Japan, after becoming Gyros's exclusive distributor for that market in July (www.clinica.co.uk, 14 July 2011). Gyros's automated immunoassays are used during the development of biotherapeutics and vaccines. They are designed to cut the time to result significantly, increase productivity and reduce development times, according to Uppsala-based Gyros. The products, which are also available in the US and Europe, complement GE's own offerings to the biopharma market, its Biacore and Microcal analytical systems.